Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Researchers identify how bone-marrow stem cells hold their 'breath' in low-oxygen environments

September 2, 2010 10:31 pm | by EurekAlert | News | Comments

(UT Southwestern Medical Center) UT Southwestern Medical Center researchers have identified unique metabolic properties that allow a specific type of stem cell in the body to survive and replicate in low-oxygen environments.

Scientists discover the mechanisms and function of a type of mysterious immune cell

September 2, 2010 1:32 pm | by EurekAlert | News | Comments

(Scripps Research Institute) In two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs. The findings may lead to the development of new therapies to treat...

Lung cancer survival rates improved through use of individualized chemotherapy

August 31, 2010 9:32 pm | by EurekAlert | News | Comments

(International Association for the Study of Lung Cancer) Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing...


Tumor budding identified as predictor for unfavorable outcome in lung cancer

August 31, 2010 9:32 pm | by EurekAlert | News | Comments

(International Association for the Study of Lung Cancer) Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one type of lung cancer, adenocarcinoma, has been increasing in recent years.

Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery

August 31, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 31 /- Masimo (Nasdaq: MASI ) announced today that a new randomized controlled trial published in Anesthesia & Analgesia shows that clinicians using Masimo Pleth Variability Index (PVI®) significantly improved fluid management and reduced lactate levels in...

Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study

August 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Aug. 30 /- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of new data supporting the safety and efficacy of Caldolor® ( ibuprofen ) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the...

Bend Research Receives Patent for Preparing Spray-Dried Drug Dispersions Using Pressure Nozzles

August 30, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

BEND, Ore., Aug. 30 /- Bend Research Inc. ( ), a leading independent drug-formulation development and manufacturing company, announced today that it has received a new U.S. patent covering a process for making spray-dried solid amorphous dispersions of drugs using pressure...

Covidien Completes Sale of Sleep Therapy Product Line

August 30, 2010 3:32 am | by Covidien | News | Comments

DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a...


New genomic marker for tuberculosis may help identify patients who will develop the disease

August 29, 2010 10:31 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease. These findings are from an international study published in the Aug. 19 issue of Nature and conducted by...

Shire Announces European Approval of VPRIV & #174; (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

August 27, 2010 6:33 am | by RealWire | News | Comments

Cambridge, MA, US - August, 27th 2010 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV® (velaglucerase alfa), a human cell line derived enzyme replacement...

JCI table of contents: Aug. 25, 2010

August 25, 2010 2:32 pm | by EurekAlert | News | Comments

(Journal of Clinical Investigation) This release contains summaries, links to PDFs, and contact information for papers to be published Aug. 25, 2010, in the JCI: Applying stem cell technology to liver diseases; Antifreeze molecule enhances survival of bacteria-carrying ticks; Immune...

Use the common cold virus to target and disrupt cancer cells?

August 25, 2010 2:31 pm | by EurekAlert | News | Comments

(Salk Institute) A novel mechanism used by adenovirus to sidestep the cell's suicide program, could go a long way to explain how tumor suppressor genes are silenced in tumor cells and pave the way for a new type of targeted cancer therapy, report researchers at the Salk Institute for...

Echo Therapeutics Announces Successful Completion of Clinical Trial for Preludeâ„¢ SkinPrep System and 4% Lidocaine Cream

August 24, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., Aug. 24 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphonyâ„¢ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Preludeâ„¢ SkinPrep System for transdermal drug...


Hospira Japan Receives Approval for New Indication for 'Precedex IVâ„¢ 200ug'

August 22, 2010 8:34 pm | by Bio-Medicine.Org | News | Comments

OSAKA, Japan, Aug. 22 /- Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this...

New 'Heroes of Chemistry' invented medicines that help millions of people

August 22, 2010 4:34 pm | by EurekAlert | News | Comments

(American Chemical Society) It's a tale of two pills: One that helps millions of people with diabetes maintain normal blood sugar levels and another that helps millions in their effort to quit smoking. The two teams that invented these potentially life-saving drugs -- Januvia and Chantix...

Cigarette smoke causes harmful changes in the lungs even at the lowest levels

August 19, 2010 9:32 pm | by EurekAlert | News | Comments

(New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) Casual smokers may think that smoking a few cigarettes a week is "no big deal." But according to new research from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical...

AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality

August 18, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

NORTH WALES, Pa., Aug. 18 /- AirPal ®, a leading innovator and supplier of lateral air transfer and positioning technology, has announced the expansion of its line of air-activated transfer pads to incorporate multi-purpose patient positioning functionality. "This announcement marks...

Advanced Life Sciences to Participate in Key Infectious Disease Conference

August 17, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Aug. 17 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the...

VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions

August 17, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

CORAL SPRINGS, Fla., Aug. 17 /- VirtuOx, Inc., a medical technology services company and industry leader in delivering home sleep testing solutions, today announced an agreement with Watermark Medical, a privately-held, medical products and services company currently servicing the...

Oridion to Present Results to New Study for the Integrated Pulmonary Index(TM) at ATACCC Conference

August 17, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

Oridion to Present Results to New Study for the Integrated Pulmonary... -- JERUSALEM and NEEDHAM, Massachusetts, August 17, 2010 /-

Springer adds Neurotherapeutics to journals portfolio

August 16, 2010 10:33 am | by EurekAlert | News | Comments

(Springer) Beginning in 2011, Springer will publish Neurotherapeutics, the official Journal of the American Society for Experimental NeuroTherapeutics. With the switch to Springer, Neurotherapeutics will change its format of publishing review articles only to offering original research...

PRA International Hosts Audio Conference on CV Drug Development

August 16, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., Aug. 16 /- PRA International, a leading Clinical Research Organization, will host an audio conference on strategies for successful cardiovascular (CV) drug development on 24 August 2010 at 11:30 am (EDT). Dr. Michael Kirchengast, Vice President and Head of PRA's Scientific...

North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group

August 16, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

DALLAS, Aug. 16 /- North American Spine is pleased to announce that Robert R. Bulger, M.D. has joined our group to help further the advancement of minimally invasive back pain treatment techniques.  The AccuraScope™ Discectomy and Neural Decompression (D.N.D.) procedure treats...

Rising Burden of Diseases Drives the Pharmaceutical Industry in East Africa, Says Frost & Sullivan

August 16, 2010 2:32 am | by Bio-Medicine.Org | News | Comments

CAPE TOWN, South Africa, Aug. 16 /- Infectious diseases are rampant in sub-Saharan Africa. Urbanisation and westernised lifestyles have further increased the prevalence of non-communicable diseases such as cancer. The strong correlation between infectious diseases and cancer has...

Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells

August 15, 2010 11:31 am | by EurekAlert | News | Comments

(Massachusetts Institute of Technology) Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.